Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 85
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can a Meal Replacement Help Solve Hunger in America?

    In the United States, hunger is commonplace. 42 million Americans struggle to get the healthy foods they need...

    Does Zika virus replicate in neural cells?

    Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

    Crowdcuring the Blues: People, Technology and Research Against Depression

    Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

    Backer Badge Funded